Inactive Instrument

Press Releases Stellar Biotechnologies Inc Nasdaq

Equities

CA85855A2039

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference	04-12	AQ
Edesa Biotech to Participate in Barclays Global Healthcare Conference	03-08	AQ
Regulators Approve Updated Phase 3 Trial Design for Edesa Biotech's ARDS Drug	26/10/23	AQ
Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate	29/09/23	AQ
Edesa Biotech to Participate in Swiss Biotech Day	21/04/23	AQ
Edesa Biotech - The WHO and USAN Adopt Generic Name for Edesa's ARDS Drug Candidate	05/04/23	AQ
EDESA BIOTECH, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	27/03/23	AQ
EDESA BIOTECH, INC. : Regulation FD Disclosure (form 8-K)	13/03/23	AQ
Edesa Biotech Reports Fiscal 1st Quarter 2023 Results	13/02/23	AQ
EDESA BIOTECH, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	10/02/23	AQ
EDESA BIOTECH, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	10/02/23	AQ
Edesa Biotech Reports Topline Phase 2b Results for Dermatology Drug	18/01/23	AQ
Edesa Biotech Reports Fiscal Year 2022 Results	19/12/22	AQ
EDESA BIOTECH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	16/12/22	AQ
EDESA BIOTECH, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	16/12/22	AQ
Edesa Biotech to Participate in the 2022 Cantor Fitzgerald Dermatology Conference	05/12/22	AQ
EDESA BIOTECH, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	03/11/22	AQ
Edesa Biotech Reports Statistically Significant Mortality Reductions in Phase 2 ARDS Drug Study	03/10/22	AQ
Edesa Biotech : Reports Fiscal 3rd Quarter 2022 Results - Form 8-K	12/08/22	PU
EDESA BIOTECH, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	12/08/22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Stellar Biotechnologies Inc Nasdaq

Equities

CA85855A2039

Press Releases

Filters